Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

N-Butyl-4,6-diphenyl-pyrimidin-2-amine.

ABSTRACT: In the title compound, C(20)H(21)N(3), the pyrimidine ring is inclined at dihedral angles of 51.57?(4) and 2.49?(4)° to the two phenyl rings. The dihedral angle between the two terminal phenyl rings is 50.44?(4)°. In the crystal, adjacent mol-ecules are linked via a pair of N-H?N hydrogen bonds, forming an inversion dimer with an R(2) (2)(8) ring motif. Furthermore, the crystal structure is stabilized by a weak ?-? inter-action, with a centroid-centroid distance of 3.6065?(5)?Å.

SUBMITTER: Fun HK

PROVIDER: S-EPMC3247364 | biostudies-literature | 2011 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

N-Butyl-4,6-diphenyl-pyrimidin-2-amine.

Fun Hoong-Kun HK Hemamalini Madhukar M Hazra Anita A Goswami Shyamaprosad S

Acta crystallographica. Section E, Structure reports online 20111012 Pt 11

In the title compound, C(20)H(21)N(3), the pyrimidine ring is inclined at dihedral angles of 51.57 (4) and 2.49 (4)° to the two phenyl rings. The dihedral angle between the two terminal phenyl rings is 50.44 (4)°. In the crystal, adjacent mol-ecules are linked via a pair of N-H⋯N hydrogen bonds, forming an inversion dimer with an R(2) (2)(8) ring motif. Furthermore, the crystal structure is stabilized by a weak π-π inter-action, with a centroid-centroid distance of 3.6065 (5) Å. ...[more]

PMID: 22219982

Similar Datasets

4,6-Dimethyl-pyrimidin-2-amine.

Project description:The asymmetric unit of the title compound, C6H9N3, contains three crystallographically independent mol-ecules of similar geometry. All of the mol-ecules are almost planar, with r.m.s. deviations of 0.003, 0.016 and 0.005?Å. In the crystal, the mol-ecules are linked by N-H?N hydrogen bonds into zigzag ribbons parallel to the c axis, generating rings of R2(2)(8) graph-set motif.

| S-EPMC3588386 | biostudies-other

N-(4,6-Dimethyl-pyrimidin-2-yl)-1H-benzimidazol-2-amine.

Project description:There are two independent mol-ecules in the asymmetric unit of the title compound, C(13)H(13)N(5). In each mol-ecule, an amino N atom is connected to a benzimidazole fused-ring system and a pyrimidine ring [these are aligned at 1.3 (1)° in one independent mol-ecule and at 5.4 (1)° in the other]. The amino N atom of the fused ring forms an intra-molecular N-H⋯O hydrogen bond to a pyrimidine N atom in each mol-ecule. The amino N atom connecting the two ring systems inter-acts with the other N atom of the pyrimidine ring of an adjacent mol-ecule, generating centrosymmetric hydrogen-bonded dimers.

| S-EPMC3052168 | biostudies-literature

N-Butyl-4-methyl-6-phenyl-pyrimidin-2-amine.

Project description:In the title compound, C(15)H(19)N(3), the pyrimidine ring is approximately planar [maximum deviation = 0.007?(1)?Å] and forms a dihedral angle of 3.15?(6)° with the benzene ring. In the crystal packing, inter-molecular N-H?N hydrogen bonds link pairs of neighbouring mol-ecules into dimers with R(2) (2)(8) ring motifs. These dimers are stacked along the b axis.

| S-EPMC2984044 | biostudies-literature

N-(4,6-Dimethyl-pyrimidin-2-yl)-1,3-benzothia-zol-2-amine.

Project description:In the title compound, C(13)H(12)N(4)S, an amino N atom is connected to a 1,3-benzothia-zole fused-ring system and a dimethyl-substituted pyrimidine ring, these components being aligned [inter-planar dihedral angle = 1.9?(1)°]. The secondary amino N atom forms an inter-molecular N-H?N hydrogen bond to an N atom of the fused ring of an adjacent mol-ecule, generating a centrosymmetric cyclic hydrogen-bonded dimer [graph set R(2) (2)(8)].

| S-EPMC3247515 | biostudies-literature

N-Cyclo-hexyl-N-{[3-(4,6-dimeth-oxy-pyrimidin-2-yl-oxy)pyridin-2-yl]meth-yl}4,6-dimeth-oxy-pyrimidin-2-amine.

Project description:In the title compound, C(24)H(30)N(6)O(5), the cyclo-hexyl ring adopts a chair conformation, while the remainder of the mol-ecule adopts a U-shape. The dihedral angles between the pyridine ring and the pendant pyrimidine rings are 69.04?(12) and 75.99?(9)°. The two pyrimidine rings, however, are nearly parallel to one another, with a dihedral angle of 8.56?(15)° between them. They are also involved in an intra-molecular ?-? stacking inter-action with a distance of 3.6627?(18)?Å between the ring centroids. In the crystal, C-H?O contacts link the mol-ecules into chains along the b axis.

| S-EPMC3344196 | biostudies-literature

4,6-Dimeth-oxy-pyrimidin-2-amine-2-(1H-indol-3-yl)acetic acid (1/1).

Project description:In the title co-crystal C(6)H(9)N(3)O(2)·C(10)H(9)NO(2), the 4,6-dimeth-oxy-pyrimidin-2-amine mol-ecule inter-acts with the carboxyl group of the 2-(1H-indol-3-yl)acetic acid mol-ecule through N-H⋯O and O-H⋯N hydrogen bonds, forming a cyclic hydrogen-bonded R(2) (2)(8) motif, which is further linked by an N-H⋯N hydrogen bond, forming a supra-molecular chain along the c axis. Neighboring chains are inter-linked via C-H⋯O hydrogen bonds, forming a supra-molecular ladder.

| S-EPMC2983259 | biostudies-literature

Discovery of 4,6-bis(2-((<i>E</i>)-benzylidene)hydrazinyl)pyrimidin-2-Amine with Antibiotic Activity.

Project description:Robenidine (E)-N'-((E)-1-(4-chlorophenyl)ethylidene)-2-(1-(4-chlorophenyl)ethylidene)hydrazine-1-carboximidhydrazide displays methicillin-resistant Staphyoccoccus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) MICs of 2 μg mL-1. Herein we describe the structure-activity relationship development of a novel series of guanidine to 2-aminopyrimidine isosteres that ameliorate the low levels of mammalian cytotoxicity in the lead compound while retaining good antibiotic activity. Removal of the 2-NH2 pyrimidine moiety renders these analogues inactive. Introduction of a central 2-NH2 triazine moiety saw a 10-fold activity reduction. Phenyl to cyclohexyl isosteres were inactive. The 4-BrPh and 4-CH3Ph with MIC values of 2 and 4 μg mL-1, against MRSA and VRE respectively, are promising candidates for future development.

| S-EPMC6610448 | biostudies-literature

Aqua-chlorido-(2-{[6-(di-methyl-amino)-pyrimidin-4-yl]sulfan-yl}pyrimidine-4,6-di-amine)-copper(II) chloride hydrate.

Project description:A copper(II) complex of the non-symmetric bidentate ligand 2-{[6-(di-methyl-amino)-pyrimidin-4-yl]sulfan-yl}pyrimidine-4,6-di-amine (L1) is reported. The single-crystal X-ray structure of aqua-[aqua/chlorido-(0.49/0.51)](2-{[6-(di-methyl-amino)-pyrimidin-4-yl]sulfan-yl}pyrimidine-4,6-di-amine)-copper(II) 0.49-chloride 1.51-hydrate, [CuCl1.51(C10H13N7S)(H2O)1.49]Cl0.49·1.51H2O or [(L1)Cl1.51(H2O)1.49Cu]0.49Cl·1.51H2O, exhibits distorted square-pyramidal geometry around the metal centre, with disorder in the axial position, occupied by chloride or water. The six-membered metal-chelate ring is in a boat conformation, and short inter-molecular S⋯S inter-actions are observed. In addition to its capacity for bidentate metal coordination, the ligand has the ability to engage in further supra-molecular inter-actions as both a hydrogen-bond donor and acceptor, and multiple inter-actions with lattice solvent water mol-ecules are present in the reported structure.

| S-EPMC5730312 | biostudies-literature

5-Iodo-pyrimidin-2-amine.

Project description:The mol-ecule of the title compound, C(4)H(4)IN(3), has crystallographic mirror plane symmetry. In the crystal, the mol-ecules are connected through N-H?N hydrogen bonds into polymeric tapes extended along the a axis, which are typical of 2-amino-pyrimidines. Each mol-ecule acts as a double donor and a double acceptor in the hydrogen bonding.

| S-EPMC2979631 | biostudies-literature

2-Chloro-pyrimidin-4-amine.

Project description:In the title pyrimidine derivative, C(4)H(4)ClN(3), the 2-chloro and 4-amino substituents almost lie in the mean plane of the pyrimidine ring, with deviations of 0.003 (1) Å for the Cl atom, and 0.020 (1) Å for the N atom. In the crystal, molecules are linked via pairs of N-H⋯N hydrogen bonds, forming inversion dimers. These dimers are further linked via N-H⋯N hydrogen bonds, forming an undulating two-dimensional network lying parallel to (100).

| S-EPMC3274995 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data